Testing effectiveness (Phase 2)WithdrawnNCT02856867
What this trial is testing
Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)
Who this might be right for
Esophagogastric AdenocarcinomaMetastatic DiseaseNo Previous Chemotherapy for Metastatic Esophagogastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC